Home
TCG Crossover GP II reported a 5.5% stake in Monte Rosa Therapeutics GLUE · 4,622,151 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 5.5%
- Last report
- 7.2% · filed 25/10/17
- Shares held
- 4,622,151 sh
- Class
- Common Stock, par value $0.0001 per share
- Holder
- TCG Crossover GP II
- Event date
- 26/03/31
- Filed
- 26/05/15
5.5% stake · −1.7pp from the last report
- Stake
- 5.5%
- Last report
- 7.2%
- Since last report
- −1.7pp
Monte Rosa Therapeutics trades, last 26 weeks
What else happened in Monte Rosa Therapeutics around then
Filed or reported within 30 days of the trade day · 03/01~04/30TCG Crossover GP II's other 5% stake reports
- TCG Crossover GP II
5% stakeAlx Oncology Holdings
5% stakeAlx Oncology Holdings
ALXO
4.2% stake
5,655,487 sh
4.2% stake
Filed 08/14
- TCG Crossover GP II
5% stakeFirst Tracks Biotherapeutics
5% stakeFirst Tracks Biotherapeutics
TRAX
8.3% stake
2,895,304 sh
8.3% stake
Filed 08/14
- TCG Crossover GP II
5% stakeFulcrum Therapeutics
5% stakeFulcrum Therapeutics
FULC
0% stake
0 sh
0% stake
Filed 08/14
- TCG Crossover GP II
5% stakeLB Pharmaceuticals
5% stakeLB Pharmaceuticals
LBRX
5% stake
1,447,310 sh
5% stake
Filed 08/14
- TCG Crossover GP II
5% stakeTango Therapeutics
5% stakeTango Therapeutics
TNGX
7% stake
10,147,867 sh
7% stake
Filed 08/14
